A detailed history of D. E. Shaw & Co., Inc. transactions in Johnson & Johnson stock. As of the latest transaction made, D. E. Shaw & Co., Inc. holds 163,900 shares of JNJ stock, worth $26.4 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares
163,900
Previous 285,200 42.53%
Holding current value
$26.4 Million
Previous $45.1 Million 46.9%
% of portfolio
0.02%
Previous 0.04%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$144.38 - $157.78 $32.5 Million - $35.5 Million
225,124 Added 23.98%
1,163,950 $170 Million
Q1 2024

May 15, 2024

SELL
$155.22 - $162.74 $76 Million - $79.7 Million
-489,770 Reduced 34.28%
938,826 $149 Million
Q4 2023

Feb 14, 2024

SELL
$145.6 - $158.88 $130 Million - $142 Million
-891,415 Reduced 38.42%
1,428,596 $224 Million
Q3 2023

Nov 14, 2023

BUY
$155.75 - $174.48 $178 Million - $199 Million
1,141,333 Added 96.83%
2,320,011 $361 Million
Q2 2023

Aug 14, 2023

SELL
$154.35 - $166.11 $424 Million - $457 Million
-2,748,548 Reduced 69.99%
1,178,678 $195 Million
Q1 2023

May 15, 2023

BUY
$151.05 - $180.26 $313 Million - $374 Million
2,074,504 Added 111.97%
3,927,226 $609 Million
Q4 2022

Feb 14, 2023

BUY
$160.2 - $179.79 $883,983 - $992,081
5,518 Added 0.3%
1,852,722 $327 Million
Q3 2022

Nov 14, 2022

BUY
$161.33 - $179.52 $172 Million - $191 Million
1,063,282 Added 135.64%
1,847,204 $302 Million
Q2 2022

Aug 15, 2022

SELL
$168.19 - $186.01 $114 Million - $126 Million
-678,480 Reduced 46.39%
783,922 $139 Million
Q1 2022

May 16, 2022

BUY
$158.14 - $179.59 $67.6 Million - $76.8 Million
427,382 Added 41.29%
1,462,402 $259 Million
Q4 2021

Feb 14, 2022

SELL
$155.93 - $173.01 $23.9 Million - $26.5 Million
-153,005 Reduced 12.88%
1,035,020 $177 Million
Q3 2021

Nov 15, 2021

SELL
$161.5 - $179.47 $89.6 Million - $99.6 Million
-554,940 Reduced 31.84%
1,188,025 $192 Million
Q2 2021

Aug 16, 2021

SELL
$159.48 - $171.07 $85.6 Million - $91.8 Million
-536,658 Reduced 23.54%
1,742,965 $287 Million
Q1 2021

May 17, 2021

SELL
$153.07 - $170.48 $82 Million - $91.3 Million
-535,586 Reduced 19.02%
2,279,623 $375 Million
Q4 2020

Feb 16, 2021

SELL
$137.11 - $157.38 $203 Million - $233 Million
-1,480,752 Reduced 34.47%
2,815,209 $443 Million
Q3 2020

Nov 16, 2020

SELL
$140.38 - $153.83 $62.3 Million - $68.3 Million
-443,967 Reduced 9.37%
4,295,961 $640 Million
Q2 2020

Aug 14, 2020

SELL
$128.81 - $155.51 $69.6 Million - $84.1 Million
-540,493 Reduced 10.24%
4,739,928 $667 Million
Q1 2020

May 15, 2020

SELL
$111.14 - $153.99 $92.8 Million - $129 Million
-834,716 Reduced 13.65%
5,280,421 $692 Million
Q4 2019

Feb 14, 2020

SELL
$127.5 - $146.44 $171 Million - $197 Million
-1,344,557 Reduced 18.02%
6,115,137 $892 Million
Q3 2019

Nov 14, 2019

BUY
$126.95 - $142.14 $175 Million - $196 Million
1,378,199 Added 22.66%
7,459,694 $965 Million
Q2 2019

Aug 14, 2019

BUY
$131.15 - $144.24 $358 Million - $393 Million
2,726,614 Added 81.27%
6,081,495 $847 Million
Q1 2019

May 15, 2019

BUY
$125.72 - $139.79 $277 Million - $308 Million
2,201,273 Added 190.82%
3,354,881 $469 Million
Q4 2018

Feb 14, 2019

BUY
$122.84 - $147.84 $73.9 Million - $88.9 Million
601,485 Added 108.94%
1,153,608 $149 Million
Q3 2018

Nov 14, 2018

SELL
$121.58 - $142.88 $224 Million - $263 Million
-1,838,726 Reduced 76.91%
552,123 $76.3 Million
Q2 2018

Aug 14, 2018

BUY
$119.4 - $131.76 $134 Million - $148 Million
1,124,994 Added 88.87%
2,390,849 $290 Million
Q1 2018

May 15, 2018

SELL
$125.1 - $148.14 $244 Million - $290 Million
-1,954,286 Reduced 60.69%
1,265,855 $162 Million
Q4 2017

Feb 14, 2018

SELL
$131.22 - $143.62 $78.5 Million - $85.9 Million
-597,910 Reduced 15.66%
3,220,141 $450 Million
Q3 2017

Nov 14, 2017

BUY
$129.47 - $135.38 $494 Million - $517 Million
3,818,051
3,818,051 $496 Million

Others Institutions Holding JNJ

About JOHNSON & JOHNSON


  • Ticker JNJ
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,614,479,872
  • Market Cap $422B
  • Description
  • Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...
More about JNJ
Track This Portfolio

Track D. E. Shaw & Co., Inc. Portfolio

Follow D. E. Shaw & Co., Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of D. E. Shaw & Co., Inc., based on Form 13F filings with the SEC.

News

Stay updated on D. E. Shaw & Co., Inc. with notifications on news.